IME vs MVP

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

IME

IMEXHS FPO [IME]

50MEDIUM

MVP

MEDICALDEV FPO [MVP]

50MEDIUM

Score Breakdown

IME MVP
Technical
66
69
Catalyst
50
50
Sentiment
50
50
Fundamental
88
88
Momentum
69
41
Risk Gate
35
50

Key Metrics

IME Metric MVP
$21.6MMarket Cap$43.9M
N/AAvg Volume (20d)105K
N/AShort InterestN/A
$0.47052-Week High$0.765
$0.22052-Week Low$0.380
+0.0%Daily Change+2.6%
$0.400Entry Price$0.390
-19.0%ROE-0.8%
-9.9%Profit Margin-1.1%

Active Signals

IME Signals

●RSI drifting toward oversold territory — worth watching
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Cash positive / operating cashflow positive
●Low P/S ratio (0.7x)
●Strong revenue growth (+21%)
●EPS estimates revised upward (+10pts)
●Small-cap ($20-100M)

MVP Signals

●RSI drifting toward oversold territory — worth watching
●MACD just crossed bullish — momentum is shifting to the upside
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Above-average volume (1.8x) on a green day — buyers stepping up
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive

Ask Scout AI to compare IME and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
IME Full Analysis → MVP Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).